Personalized radiation for early stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of non-small cell lung cancer that is stage IA or IIA (early stage) and located in the outer part of the lung (at least 2 cm from the main airways or chest center).
- You must be unable to have surgery because of poor lung function, heart problems, or similar reasons, or you have chosen not to have surgery.
- You must be in fairly good overall health (able to care for yourself and up and about more than 50% of waking hours).
- You must not have had previous radiation, chemotherapy, targeted therapy, or surgery for lung cancer.
- You must not have any other active cancer (except certain skin cancers or cervical pre-cancer that was treated within the last 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single very high dose of precisely targeted radiation to treat early-stage lung cancer. It aims to destroy the tumor with one treatment session, which may be more convenient and effective than standard radiation.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial studies how detailed tests (“multi-omics” modeling) can improve how doctors plan and deliver stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer. It may help make treatment planning more precise for cancers in stages I–II.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests how a single, high-dose radiation treatment (called SBRT) affects quality of life and outcomes for people with certain lung tumors. It's for adults with early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer, as long as the tumor is small and in the outer part of the lung.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
Hear when a new Early-stage Peripheral Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.